Federal rulemaking [electronic resource] : improvements needed to monitoring and evaluation of rules development as well as to the transparency of OMB regulatory reviews : report to the Chairman, Committee on Oversight and Government Reform, House of Representatives.
Title from cover screen (GAO, viewed May 13, 2009). "April 2009." Includes bibliographical references. "GAO-09-205."
Summary:
Regulation is one of the principal tools that the government uses to implement public policy. As part of the rulemaking process federal agencies must comply with an increasing number of procedural and analytical requirements. GAO was asked to examine how broadly applicable rulemaking requirements cumulatively have affected (1) agencies' rulemaking processes, in particular including effects of requirements added to the process since 2003, and (2) transparency of the Office of Information and Regulatory Affairs (OIRA) regulatory review process. To address these objectives, GAO reviewed selected rules issued between January 2006 and May 2008 and associated dockets and also interviewed knowledgeable agency and OIRA officials. GAO recommends that, consistent with internal control standards, the Environmental Protection Agency (EPA), Food and Drug Administration (FDA), and Securities and Exchange Commission (SEC) track and evaluate actual performance versus targeted milestones for developing significant rules to identify process improvement opportunities. GAO also recommends that OMB should provide additional guidance to agencies to improve transparency and documentation of the OIRA review process.
OCLC:
(OCoLC)320914435
Locations:
USUX851 -- Iowa State University - Parks Library (Ames)
This resource is supported by the Institute of Museum and Library Services under the provisions of the Library Services and Technology Act as administered by State Library of Iowa.